{
    "id": 3707,
    "name": "endometrial mucinous adenocarcinoma",
    "source": "DOID",
    "definition": "An endometrial adenocarcinoma that derives_from epithelial cells originating in glandular tissue, which produce mucin. [url:https\\://www.ncbi.nlm.nih.gov/pubmed/22569105]",
    "currentPreferredTerm": null,
    "lastUpdateDateFromDO": "03/24/2020",
    "altIds": [
        
    ],
    "termId": "DOID:3707",
    "evidence": [
        
    ],
    "clinicalTrials": [
        {
            "nctId": "NCT00492778",
            "title": "Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer",
            "phase": "Phase II",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 700,
                    "therapyName": "Cisplatin",
                    "synonyms": null
                }
            ]
        },
        {
            "nctId": "NCT03694262",
            "title": "The EndoBARR Trial (Endometrial Bevacizumab, Atezolizumab, Rucaparib) (EndoBARR)",
            "phase": "Phase II",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 7499,
                    "therapyName": "Atezolizumab + Bevacizumab + Rucaparib",
                    "synonyms": null
                }
            ]
        }
    ]
}